Abbott Laboratories’s filing revealed that its CHAIRMAN AND CEO Ford Robert B unloaded Company’s shares for reported $16.49 million on Sep 12 ’24. In the deal valued at $116.41 per share,141,679 shares were sold. As a result of this transaction, Ford Robert B now holds 220,059 shares worth roughly $25.09 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Robert B. Ford bought 141,679 shares, generating $16,492,852 in total proceeds.
Before that, MCCOY JOHN A. JR. sold 27 shares. Abbott Laboratories shares valued at $3,100 were divested by the VICE PRESIDENT at a price of $114.83 per share. As a result of the transaction, MCCOY JOHN A. JR. now holds 18,681 shares, worth roughly $2.13 million.
Piper Sandler initiated its Abbott Laboratories [ABT] rating to an Overweight in a research note published on September 19, 2024; the price target was $131. A number of analysts have revised their coverage, including Edward Jones’s analysts, who decreased its forecast for the stock in late July from “a Buy” to “a Hold”. Goldman began covering ABT with “Buy” recommendation on May 30, 2024. Wolfe Research revised its rating on July 21, 2023. It rated ABT as “a Peer perform” which previously was an “an Underperform”.
Price Performance Review of ABT
On Monday, Abbott Laboratories [NYSE:ABT] saw its stock jump 1.41% to $114.01. Over the last five days, the stock has lost -0.70%. Abbott Laboratories shares have risen nearly 3.58% since the year began. Nevertheless, the stocks have risen 16.19% over the past one year. While a 52-week high of $121.64 was reached on 03/08/24, a 52-week low of $89.67 was recorded on 07/18/24. SMA at 50 days reached $111.59, while 200 days put it at $109.98.
Levels Of Support And Resistance For ABT Stock
The 24-hour chart illustrates a support level at 112.71, which if violated will result in even more drops to 111.41. On the upside, there is a resistance level at 114.70. A further resistance level may holdings at 115.39. The Relative Strength Index (RSI) on the 14-day chart is 52.04, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.82, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 67.71%. Stochastics %K at 18.04% indicates the stock is a buying.
How much short interest is there in Abbott Laboratories?
A steep rise in short interest was recorded in Abbott Laboratories stocks on 2024-09-13, growing by 0.68 million shares to a total of 13.36 million shares. Yahoo Finance data shows the prior-month short interest on 2024-08-15 was 12.68 million shares. There was a rise of 5.11%, which implies that there is a positive sentiment for the stock.
